Metabolism and interaction of bisphenol A in human hepatic cytochrome p450and steroidogenic CYP17
Citation
T. Niwa et al., Metabolism and interaction of bisphenol A in human hepatic cytochrome p450and steroidogenic CYP17, BIOL PHAR B, 24(9), 2001, pp. 1064-1067
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BIOLOGICAL & PHARMACEUTICAL BULLETIN
SICI code
0918-6158(200109)24:9<1064:MAIOBA>2.0.ZU;2-#
Abstract
The metabolism of bisphenol A (BPA) was determined for 11 forms of human he
patic cytochromes P450 (CYPs) expressed in the yeast Saccharomyces cerevisi
ae and for human steroidogenic CYP17 expressed in Escherichia coli Addition
ally, the effect of BPA on the progesterone 17 alpha -hydroxylase activity
of CYP17 was investigated. CYP2C18 catalyzed BPA metabolism most efficientl
y, followed by CYP2C19 and CYNC9. CYP2C9 and CYT2C18 exhibited the highest
affinity (K-m,=3.9 muM) for BPA metabolism. The V-max, of CYP2C18 (8.10 nmo
l (.) min(-1) (.) nmol CYP-1) was 5 times higher than that of CYP2C9. Altho
ugh the V-max of CYP2C19 was 1.5 times higher than that of CYP2C18, the aff
inity of CYP2C19 was 12 times lower than that of CYP2C9 and CYP2C18. Theref
ore the intrinsic clearance (V-max/K-m) of CYP2C18 was more than 5 times hi
gher than that of CYP2C9 and CYP2C19. On the other hand, BPA exhibited a co
mpetitive-type inhibition of the progesterone 17 alpha -hydroxylase activit
y of CYP17 with a Ki value of 71 muM, whereas no metabolism of BPA by CYP17
was detected. These results suggest that BPA is mainly metabolized by the
CYP2C subfamily in human liver, and that BPA inhibits human steroidogenic C
YP17 activities.